Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1

PHASE3CompletedINTERVENTIONAL
Enrollment

1,329

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

January 3, 2017

Conditions
Infertility
Interventions
DRUG

Follitropin Delta (FE 999049)

DRUG

Follitropin Alfa (GONAL-F)

Trial Locations (13)

Unknown

UZ Brussel (there may be other sites in this country), Brussels

Fertilitat and PUC-RS (there may be other sites in this country), Porto Alegre

Pacific Centre for Reproductive Medicine, Burnaby

Olive Fertility Centre, Vancouver

Ottawa Fertility Centre, Ottawa

IVF CUBE SE (there may be other sites in this country), Prague

Rigshospitalet Fertilitetsklinikken (there may be other sites in this country), Copenhagen

Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre (there may be other sites in this country), Lille

Centro Natalità San Raffaele (there may be other sites in this country), Milan

The nOvum Clinic (there may be other sites in this country), Warsaw

IVF & Reproductive Genetics Center (there may be other sites in this country), Moscow

IVI Sevilla (there may be other sites in this country), Seville

Glasgow Centre for Reproductive Medicine Ltd. (there may be other sites in this country), Glasgow

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT01956110 - Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 | Biotech Hunter | Biotech Hunter